Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Medicratic
AddedFeb 16, 2024
UpdatedJun 18, 2026
Medicratic

Medicratic

Texas-based Medicratic offers a SAAS platform for streamlining evaluations in medical education.

HQ
Richardson, TX, US
Founded
2023
Overview
Compare
Fundraising
Employees
Website

Founded in Richardson, Texas, Medicratic is a software-as-a-service (SAAS) company dedicated to enhancing the evaluation process in medical education. The company's core mission is to make residency and fellowship applicant evaluations faster, more holistic, and equitable. Medicratic offers a platform called Halsted, which is designed to streamline and improve the efficiency of these evaluations. The platform is currently used by over 150 users across more than 40 institutions, reflecting its growing influence in the medical education market.

Notable affiliated people and investors have not been specified, but the company has received positive testimonials from users who appreciate its user-friendly interface and impactful results. Key achievements include the successful implementation of their platform in numerous institutions, demonstrating its value in real-world settings. Overall, Medicratic is making a significant impact by simplifying and enhancing the evaluation process in medical education, ultimately contributing to better outcomes for both educators and applicants.

Medicratic - Quick Facts

When was Medicratic founded?

Medicratic was founded in 2023.

Where is Medicratic's headquarters located?

Medicratic's headquarters is located in Richardson, TX, US.

When was Medicratic's last funding round?

Medicratic's most recent funding round was for $1M (USD) in September 2023.

How much has Medicratic raised to-date?

As of Sep 23, 2023, Medicratic has raised a total of $1M (USD).

How many employees does Medicratic have?

Medicratic has 5 employees as of Feb 5, 2024.

Medicratic - Classification

Ownership
  • Private
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • SaaS
Customer
  • Education
  • Enterprise
Main Product
  • Platform
  • Software
Tags
  • Edtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software